1. Home
  2. REGCO vs SCLXW Comparison

REGCO vs SCLXW Comparison

Compare REGCO & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

REGCO

Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

N/A

Current Price

$22.67

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.18

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGCO
SCLXW
Founded
N/A
N/A
Country
United States
United States
Employees
500
30
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REGCO
SCLXW
Price
$22.67
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
4.0K
Earning Date
N/A
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.02
52 Week Low
N/A
$0.18
52 Week High
N/A
$0.18

Technical Indicators

Market Signals
Indicator
REGCO
SCLXW
Relative Strength Index (RSI) 49.30 55.73
Support Level $22.48 $0.07
Resistance Level $23.07 $0.18
Average True Range (ATR) 0.19 0.03
MACD 0.04 0.01
Stochastic Oscillator 60.29 91.84

Price Performance

Historical Comparison
REGCO
SCLXW

About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: